starting tirzepatide after semaglutide Switching from to dosage chart Switch from Semaglutide to Tirzepatide:

Malekshah and colleagues then armed AD-MSCs with secreted carboxylesterase-2, allowing systemic irinotecan to be converted into its potent metabolite SN-38 directly inside intraperitoneal metastases

Vascular and endothelial dysfunction markers: Asymmetric dimethylarginine (ADMA) an inhibitor of nitric oxide synthesis is elevated in HF and atherosclerosis, reflecting endothelial dysfunction

Some studies suggest that carnitines ability to shift the fuel source from glycogen (carbs) to fatty acids (fat) improves performance

Increase intensity: Try adding ankle weights or increasing duration

Pancreatitis risk has been a long-standing concern